ArticleMetabolites2024

Diagnostic and Prognostic Performance of Metabolic Signatures in Pancreatic Ductal Adenocarcinoma: The Clinical Application of Quantitative NextGen Mass Spectrometry.

Paulo D'Amora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.